We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Lashes Out Against Senate Bill Allowing Medicare to Negotiate Drug Prices
PhRMA Lashes Out Against Senate Bill Allowing Medicare to Negotiate Drug Prices
The Pharmaceutical Research and Manufacturers of America (PhRMA) is incensed about the reconciliation bill the Senate passed on Sunday night, which would permit the government to negotiate with drugmakers on some prescription drug prices for the Medicare program.